FASEB J. Pierce now sold as Thermo Scientific
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pegg, A. E.
Right arrow Articles by Byers, T. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pegg, A. E.
Right arrow Articles by Byers, T. L.

The FASEB Journal, Vol 6, 2302-2310, Copyright © 1992 by The Federation of American Societies for Experimental Biology

REVIEWS

Repair of DNA containing O6-alkylguanine

AE Pegg and TL Byers
Department of Cellular and Molecular Physiology, Milton S. Hershey Medical Center, Pennsylvania State University College of Medicine, Hershey 17033.

O6-Alkylguanines, important DNA adducts formed by alkylating agents, can lead to mutations and to cell death unless repaired. The major pathway of repair involves the transfer of the alkyl group from the DNA to a cysteine acceptor site in the protein O6-alkylguanine-DNA alkyltransferase. The alkyltransferase brings about this transfer without need for cofactors and the DNA is restored completely by the action of a single protein, but the cysteine acceptor site is not regenerated and the number of O6-alkylguanines that can be repaired is equal to the number of active alkyltransferase molecules. The alkylated form of the protein is unstable in mammalian cells and is degraded rapidly. Cloning of the cDNAs for the alkyltransferase proteins from bacteria, yeast, and mammals indicates a significant similarity, particularly in the region surrounding the cysteine acceptor site. There is a major difference in the regulation of the alkyltransferase between mammalian cells and certain bacteria, where it is induced as part of the adaptive response to alkylating agents. Regulation of the content of alkyltransferase in mammalian cells differs with species and cell type and, in some cases, the level of the protein is increased by exposure to alkylating agents or X rays. A significant fraction of human tumor cell lines do not express the alkyltransferase gene and, thus, are much more sensitive to mutagenesis and killing by alkylating agents. The frequency of primary tumor cells that lack alkyltransferase protein is not yet clear. However, it is known that the level of alkyltransferase in tumors is a significant factor in resistance to both methylating agents and bifunctional chloroethylating agents. Inactivation of the alkyltransferase, which can be brought about by pretreatment with an alkylating agent or by exposure to O6- benzylguanine (a powerful nontoxic inhibitor), sensitizes tumor cells to these chemotherapeutic alkylating agents and may prove a useful therapeutic strategy.


This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
J. N. Sarkaria, G. J. Kitange, C. D. James, R. Plummer, H. Calvert, M. Weller, and W. Wick
Mechanisms of Chemoresistance to Alkylating Agents in Malignant Glioma
Clin. Cancer Res., May 15, 2008; 14(10): 2900 - 2908.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
L. Wang, H. Liu, Z. Zhang, M. R. Spitz, and Q. Wei
Association of Genetic Variants of O6-Methylguanine-DNA Methyltransferase with Risk of Lung Cancer in Non-Hispanic Whites
Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2364 - 2369.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
J. G. Einspahr, M. E. Martinez, R. Jiang, C.-H. Hsu, A. K. Bhattacharrya, D. J. Ahnen, E. T. Jacobs, P. S. Houlihan, C. R. Webb, D. S. Alberts, et al.
Associations of Ki-ras Proto-oncogene Mutation and p53 Gene Overexpression in Sporadic Colorectal Adenomas with Demographic and Clinicopathologic Characteristics.
Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1443 - 1450.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
T. Ueno, S. H. Ko, E. Grubbs, Y. Yoshimoto, C. Augustine, Z. Abdel-Wahab, T.-Y. Cheng, O. I. Abdel-Wahab, S. K. Pruitt, H. S. Friedman, et al.
Modulation of chemotherapy resistance in regional therapy: a novel therapeutic approach to advanced extremity melanoma using intra-arterial temozolomide in combination with systemic O6-benzylguanine.
Mol. Cancer Ther., March 1, 2006; 5(3): 732 - 738.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
J. Bigler, C. M. Ulrich, T. Kawashima, J. Whitton, and J. D. Potter
DNA Repair Polymorphisms and Risk of Colorectal Adenomatous or Hyperplastic Polyps
Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2501 - 2508.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
E. Giovannucci and S. Ogino
DNA Methylation, Field Effects, and Colorectal Cancer
J Natl Cancer Inst, September 21, 2005; 97(18): 1317 - 1319.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. Neville, S. Blaney, M. Bernstein, P. Thompson, D. Adams, A. Aleksic, and S. Berg
Pharmacokinetics of O6-benzylguanine in Pediatric Patients with Central Nervous System Tumors: A Pediatric Oncology Group Study
Clin. Cancer Res., August 1, 2004; 10(15): 5072 - 5075.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
E. Barletta, G. Gorini, P. Vineis, L. Miligi, L. Davico, G. Mugnai, S. Ciolli, F. Leoni, M. Bertini, G. Matullo, et al.
Ras gene mutations in patients with acute myeloid leukaemia and exposure to chemical agents
Carcinogenesis, May 1, 2004; 25(5): 749 - 755.
[Abstract] [Full Text] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
D. Goldenberg, S. Harden, B. G. Masayesva, P. Ha, N. Benoit, W. H. Westra, W. M. Koch, D. Sidransky, and J. A. Califano
Intraoperative Molecular Margin Analysis in Head and Neck Cancer
Arch Otolaryngol Head Neck Surg, January 1, 2004; 130(1): 39 - 44.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. Nagasaka, G. B. Sharp, K. Notohara, T. Kambara, H. Sasamoto, H. Isozaki, D. G. MacPhee, J. R. Jass, N. Tanaka, and N. Matsubara
Hypermethylation of O6-Methylguanine-DNA Methyltransferase Promoter May Predict Nonrecurrence after Chemotherapy in Colorectal Cancer Cases
Clin. Cancer Res., November 1, 2003; 9(14): 5306 - 5312.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
L. van der Weyden, D. J. Adams, and A. Bradley
Tools for targeted manipulation of the mouse genome
Physiol Genomics, December 3, 2002; 11(3): 133 - 164.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
H. S. Friedman, S. Keir, A. E. Pegg, P. J. Houghton, O. M. Colvin, R. C. Moschel, D. D. Bigner, and M. E. Dolan
O6-Benzylguanine-mediated Enhancement of Chemotherapy
Mol. Cancer Ther., September 1, 2002; 1(11): 943 - 948.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. A. Quinn, J. Pluda, M. E. Dolan, S. Delaney, R. Kaplan, J. N. Rich, A. H. Friedman, D. A. Reardon, J. H. Sampson, O. M. Colvin, et al.
Phase II Trial of Carmustine Plus O6-Benzylguanine for Patients With Nitrosourea-Resistant Recurrent or Progressive Malignant Glioma
J. Clin. Oncol., May 1, 2002; 20(9): 2277 - 2283.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. Wolf, Y. C. Hu, K. Doffek, D. Sidransky, and S. A. Ahrendt
O6-Methylguanine-DNA Methyltransferase Promoter Hypermethylation Shifts the p53 Mutational Spectrum in Non-Small Cell Lung Cancer
Cancer Res., November 1, 2001; 61(22): 8113 - 8117.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
M. Ochiai, T. Ubagai, T. Kawamori, H. Imai, T. Sugimura, and H. Nakagama
High susceptibility of Scid mice to colon carcinogenesis induced by azoxymethane indicates a possible caretaker role for DNA-dependent protein kinase
Carcinogenesis, September 1, 2001; 22(9): 1551 - 1555.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. Pourquier, J. L. Waltman, Y. Urasaki, N. A. Loktionova, A. E. Pegg, J. L. Nitiss, and Y. Pommier
Topoisomerase I-mediated Cytotoxicity of N-Methyl-N'-nitro-N-nitrosoguanidine: Trapping of Topoisomerase I by the O6-Methylguanine
Cancer Res., January 1, 2001; 61(1): 53 - 58.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
S. A. Amundson, T. G. Myers, D. Scudiero, S. Kitada, J. C. Reed, and A. J. Fornace Jr.
An Informatics Approach Identifying Markers of Chemosensitivity in Human Cancer Cell Lines
Cancer Res., November 1, 2000; 60(21): 6101 - 6110.
[Abstract] [Full Text]

Home page
 JCOHome page
H. S. Friedman, J. Pluda, J. A. Quinn, R. B. Ewesuedo, L. Long, A. H. Friedman, I. Cokgor, O. M. Colvin, M. M. Haglund, D. M. Ashley, et al.
Phase I Trial of Carmustine Plus O6-Benzylguanine for Patients With Recurrent or Progressive Malignant Glioma
J. Clin. Oncol., October 20, 2000; 18(20): 3522 - 3528.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Ochs and B. Kaina
Apoptosis Induced by DNA Damage O -Methylguanine Is Bcl-2 and Caspase-9/3 Regulated and Fas/Caspase-8 Independent
Cancer Res., October 1, 2000; 60(20): 5815 - 5824.
[Abstract] [Full Text]

Home page
 CarcinogenesisHome page
H. Zhang, G. Marra, J. Jiricny, V. M. Maher, and J.J. McCormick
Mismatch repair is required for O6-methylguanine-induced homologous recombination in human fibroblasts
Carcinogenesis, September 1, 2000; 21(9): 1639 - 1646.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Ragg, M. Xu-Welliver, J. Bailey, M. D’Souza, R. Cooper, S. Chandra, R. Seshadri, A. E. Pegg, and D. A. Williams
Direct Reversal of DNA Damage by Mutant Methyltransferase Protein Protects Mice against Dose-intensified Chemotherapy and Leads to in Vivo Selection of Hematopoietic Stem Cells
Cancer Res., September 1, 2000; 60(18): 5187 - 5195.
[Abstract] [Full Text]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
M. Y. Hong, J. R. Lupton, J. S. Morris, N. Wang, R. J. Carroll, L. A. Davidson, R. H. Elder, and R. S. Chapkin
Dietary Fish Oil Reduces O6-Methylguanine DNA Adduct Levels in Rat Colon in Part by Increasing Apoptosis during Tumor Initiation
Cancer Epidemiol. Biomarkers Prev., August 1, 2000; 9(8): 819 - 826.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
S. E. Boley, T. P. McManus, V. M. Maher, and J. J. McCormick
Malignant Transformation of Human Fibroblast Cell Strain MSU-1.1 by N-Methyl-N-nitrosourea: Evidence of Elimination of p53 by Homologous Recombination
Cancer Res., August 1, 2000; 60(15): 4105 - 4111.
[Abstract] [Full Text]

Home page
 Clin. Cancer Res.Home page
H. S. Friedman, T. Kerby, and H. Calvert
Temozolomide and Treatment of Malignant Glioma
Clin. Cancer Res., July 1, 2000; 6(7): 2585 - 2597.
[Abstract] [Full Text]

Home page
 CarcinogenesisHome page
N. J. Toft, O. J. Sansom, R. A. Brookes, M. J. Arends, M. Wood, G. P. Margison, D. J. Winton, and A. R. Clarke
In vivo administration of O6-benzylguanine does not influence apoptosis or mutation frequency following DNA damage in the murine intestine, but does inhibit P450-dependent activation of dacarbazine
Carcinogenesis, April 1, 2000; 21(4): 593 - 598.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. S. Srivenugopal, S. R. S. Mullapudi, J. Shou, T. K. Hazra, and F. Ali-Osman
Protein Phosphorylation Is a Regulatory Mechanism for O6-Alkylguanine-DNA Alkyltransferase in Human Brain Tumor Cells
Cancer Res., January 1, 2000; 60(2): 282 - 287.
[Abstract] [Full Text]

Home page
 CarcinogenesisHome page
R. K. Wali, S. Skarosi, J. Hart, Y. Zhang, M.e. Dolan, R. C. Moschel, L. Nguyen, R. Mustafi, T. A. Brasitus, and M. Bissonnette
Inhibition of O6-methylguanine-DNA methyltransferase increases azoxymethane-induced colonic tumors in rats
Carcinogenesis, December 1, 1999; 20(12): 2355 - 2360.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
N. Abril, F. L. Luque-Romero, F. C. Christians, L. P. Encell, L. A. Loeb, and C. Pueyo
Human O6-alkylguanine-DNA alkyltransferase: protection against alkylating agents and sensitization to dibromoalkanes
Carcinogenesis, November 1, 1999; 20(11): 2089 - 2094.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Xu-Welliver, J. Leitao, S. Kanugula, and A. E. Pegg
Alteration of the Conserved Residue Tyrosine-158 to Histidine Renders Human O6-Alkylguanine-DNA Alkyltransferase Insensitive to the Inhibitor O6-Benzylguanine
Cancer Res., April 1, 1999; 59(7): 1514 - 1519.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S. Edara, S. Kanugula, and A. E. Pegg
Expression of the inactive C145A mutant human O6-alkylguanine-DNA alkyltransferase in E.coli increases cell killing and mutations by N-methyl-N'-nitro-N-nitrosoguanidine
Carcinogenesis, January 1, 1999; 20(1): 103 - 108.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
L. Tentori, L. Orlando, P. M. Lacal, E. Benincasa, I. Faraoni, E. Bonmassar, S. D'Atri, and G. Graziani
Inhibition of O6-Alkylguanine DNA-Alkyltransferase or Poly(ADP-ribose) Polymerase Increases Susceptibility of Leukemic Cells to Apoptosis Induced by Temozolomide
Mol. Pharmacol., August 1, 1997; 52(2): 249 - 258.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
F. Y. Chen, L. C. Harris, J. S. Remack, and T. P. Brent
Cytoplasmic sequestration of an O6-methylguanine-DNA methyltransferase enhancer binding protein in DNA repair-deficient human cells
PNAS, April 29, 1997; 94(9): 4348 - 4353.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Goodtzova, S. Kanugula, S. Edara, G. T. Pauly, R. C. Moschel, and A. E. Pegg
Repair of O6-Benzylguanine by the Escherichia coli Ada and Ogt and the Human O6-Alkylguanine-DNA Alkyltransferases
J. Biol. Chem., March 28, 1997; 272(13): 8332 - 8339.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
N. Chinnasamy, J. A. Rafferty, I. Hickson, J. Ashby, H. Tinwell, G. P. Margison, T. M. Dexter, and L. J. Fairbairn
O6-Benzylguanine Potentiates the In Vivo Toxicity and Clastogenicity of Temozolomide and BCNU in Mouse Bone Marrow
Blood, March 1, 1997; 89(5): 1566 - 1573.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. K. Bhakat and S. Mitra
Regulation of the Human O6-Methylguanine-DNA Methyltransferase Gene by Transcriptional Coactivators cAMP Response Element-binding Protein-binding Protein and p300
J. Biol. Chem., October 27, 2000; 275(44): 34197 - 34204.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by The Federation of American Societies for Experimental Biology.